Microdosing Psychedelics to Improve Mood

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This trial aims to examine the safety and efficacy of small (2mg) sub-hallucinogenic doses of psilocybin in people with Major Depressive Disorder.
Epistemonikos ID: 604823e3ccbd6c8ff5de6ee202647d79fe25bc44
First added on: May 10, 2024